Related Experiment Video
Updated: Jun 24, 2026
Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae
Published on: March 7, 2025
The use of in vivo zebrafish assays in drug toxicity screening
Peter M Eimon1, Amy L Rubinstein
1peter@zygogen.com
Abstract:
Anecdotal evidence has long suggested that zebrafish may be a good model to predict toxicity of human drugs. As summarized in this review, several groups have recently conducted systematic evaluations of zebrafish toxicity end points using large numbers of pharmacologically relevant compounds. Assays of particular interest include those for cardiotoxicity, ototoxicity, seizure liability, developmental toxicity and gastrointestinal motility. Results suggest that zebrafish assays can attain an acceptable level of predictivity, ranging from "sufficient" (65 - 75% predictivity) to "good" (75 - 85% predictivity) based on guidelines established for novel in vitro tests by the European Centre for the Validation of Alternative Methods. Further validation will probably be required to definitely establish zebrafish as a standard model for toxicity testing.
Insights
Zebrafish toxicity assays show promise for predicting human drug toxicity, with sufficient to good predictivity in key areas like cardiotoxicity. Further validation is needed to establish zebrafish as a standard toxicity testing model.
Area of Science:
- Pharmacology
- Toxicology
- Zebrafish Models
Background:
- Anecdotal evidence suggests zebrafish as a potential model for predicting human drug toxicity.
- Recent systematic evaluations have assessed zebrafish toxicity endpoints using pharmacologically relevant compounds.
Purpose of the Study:
- To review and evaluate the predictive capacity of zebrafish toxicity assays for human drug safety.
- To assess the performance of zebrafish assays against established validation guidelines.
Main Methods:
- Systematic evaluation of zebrafish toxicity endpoints.
- Testing with a large number of pharmacologically relevant compounds.
- Analysis of assays for cardiotoxicity, ototoxicity, seizure liability, developmental toxicity, and gastrointestinal motility.
Main Results:
- Zebrafish assays demonstrate acceptable predictivity, ranging from "sufficient" (65-75%) to "good" (75-85%).
- Performance is assessed based on European Centre for the Validation of Alternative Methods (ECVAM) guidelines for in vitro tests.
Conclusions:
- Zebrafish assays show significant potential for predicting drug toxicity.
- Further validation is necessary to establish zebrafish as a standardized model for toxicity testing.
